Topical agent

A technology for external preparations and extracts, which is applied in the field of external preparations containing tranexamic acid to achieve a good sense of use and good appearance

Pending Publication Date: 2021-10-22
MARUZEN PHARMA
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, although tranexamic acid is water-soluble, on the other hand, there is a problem that crystallinity is very high, and crystals are easily precipitated by evaporation of water.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Topical agent
  • Topical agent
  • Topical agent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0086] Hereinafter, the present invention will be specifically described by giving test examples and examples, but the present invention is not limited by the following examples. It should be noted that, in the following examples, unless otherwise specified, “%” in the composition means mass %, and ratios mean mass ratio. "Noni Juice" and "Lemon Juice" in the table are the amount of juice, and others are the converted amount of solid content.

[0087] For the following ingredients, the tranexamic acid crystallization inhibition test was carried out at the concentrations stated in the table. Record the results together in the table.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

This topical agent has the effect of inhibiting the crystallization of tranexamic acid, and contains (A) one or more selected from tranexamic acid, tranexamic acid derivatives, and salts thereof, and (B) one or more selected from groups: (B-1) marjoram extract, silver vine extract, plum extract, Japanese maple extract, multiflora rose fruit extract, Malva mauritiana L. extract, Arnica extract, eucalyptus extract, and royal jelly extract; (B-2) noni fruit juice and lemon juice; and (B-3) conchiolin hydrolysate and silk hydrolysate.

Description

technical field [0001] The present invention relates to external preparations containing tranexamic acid. [0002] Background of the invention [0003] Tranexamic acid has hemostatic and anti-inflammatory effects, and is widely used in toothpaste, pharmaceuticals, and the like. In addition, it has the effect of improving rough skin and whitening effect, and is also used as an external preparation for skin or hair such as cosmetics. [0004] However, although tranexamic acid is water-soluble, on the other hand, there is a problem that crystallinity is very high and crystals are easily precipitated by evaporation of water. As a method for suppressing the crystallization of such tranexamic acid, combined use of phytic acid (Patent Document 1: JP-A No. 2018-48097) and polyhydroxy acid (Patent Document 2: JP-A No. 2013-121955) has been proposed. method etc. However, a method with a better effect of inhibiting the crystallization of tranexamic acid is desired. [0005] prior ar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K8/44A61K8/64A61K8/9789A61K8/98A61K47/42A61K47/46A61K31/195A61P7/04A61P29/00A61P17/16A61Q19/00A61Q19/02
CPCA61P29/00A61K47/42A61K8/9789A61Q19/00A61K8/64A61K47/46A61K8/98A61K8/44A61K31/195A61P7/04A61P17/16
Inventor 鸟家圭悟池田良
Owner MARUZEN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products